ResearcherSichuan UniversityNo recent work listed
Yonghua Chen
Matched on ORCID iD 0009-0004-2004-4358; OpenAlex author ID A5100757192. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: 1 paper
Papers 6
- Regional differences in islet amyloid deposition in the residual pancreas with new-onset diabetes secondary to pancreatic ductal adenocarcinoma. Last author DOI 10.4240/wjgs.v15.i8.1703↗
- Comment on: Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis. First author DOI 10.1093/bjs/znac339↗
- Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis. Co-author DOI 10.4251/wjgo.v14.i10.1903↗
- Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study. Co-author DOI 10.1097/md.0000000000019327↗
- Risk of pancreatic cancer in patients undergoing surgery for chronic pancreatitis. First author DOI 10.1186/s12893-019-0537-1↗
- Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis. Last author DOI 10.3748/wjg.v25.i39.6006↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chunlu Tan · 5 shared papers, 2019–2023 · strength 0.74
- Paper Regional differences in islet amyloid deposition in the residual pancreas with new-onset diabetes secondary to pancreat… DOI 10.4240/wjgs.v15.i8.1703↗
- Paper Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis. DOI 10.4251/wjgo.v14.i10.1903↗
- Paper Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A s… DOI 10.1097/md.0000000000019327↗
- Zhenjiang Zheng · 3 shared papers, 2019–2022 · strength 0.43
- Paper Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis. DOI 10.4251/wjgo.v14.i10.1903↗
- Paper Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A s… DOI 10.1097/md.0000000000019327↗
- Paper Risk of pancreatic cancer in patients undergoing surgery for chronic pancreatitis. DOI 10.1186/s12893-019-0537-1↗
- Xu-Bao Liu · 3 shared papers, 2019–2022 · strength 0.43
- Paper Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis. DOI 10.4251/wjgo.v14.i10.1903↗
- Paper Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A s… DOI 10.1097/md.0000000000019327↗
- Paper Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis. DOI 10.3748/wjg.v25.i39.6006↗
- Guanhua Chen · 1 shared paper, 2022 · strength 0.33
- Xu-Bao Liu · 1 shared paper, 2023 · strength 0.19
- Rui Wang · 1 shared paper, 2023 · strength 0.19
- Haoqi Zhang · 1 shared paper, 2022 · strength 0.19
- Jing Li · 1 shared paper, 2022 · strength 0.19
- Xubao Liu · 1 shared paper, 2019 · strength 0.11
- Nengwen Ke · 1 shared paper, 2019 · strength 0.11
- Sheng Zhang · 1 shared paper, 2019 · strength 0.11
- Qian Feng · 1 shared paper, 2019 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.